title: Molecular subtypes of high-grade serous ovarian cancer: the holy grail?
authors.affiliation: City University of New York School of Public Health, Hunter College, New York, NY (LW); Novartis Institutes for BioMedical Research, Cambridge, MA (MR); Center for Cancer Research, Massachusetts General Hospital, Boston, MA (MB).
authors.forename: Levi
authors.initials: L
authors.lastname: Waldron
authors.affiliation: City University of New York School of Public Health, Hunter College, New York, NY (LW); Novartis Institutes for BioMedical Research, Cambridge, MA (MR); Center for Cancer Research, Massachusetts General Hospital, Boston, MA (MB).
authors.forename: Markus
authors.initials: M
authors.lastname: Riester
authors.affiliation: City University of New York School of Public Health, Hunter College, New York, NY (LW); Novartis Institutes for BioMedical Research, Cambridge, MA (MR); Center for Cancer Research, Massachusetts General Hospital, Boston, MA (MB). mbirrer@partners.org.
authors.forename: Michael
authors.initials: M
authors.lastname: Birrer
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D018284:Cystadenocarcinoma, Serous / Q000401:mortality* / Q000628:therapy*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000401:mortality* / Q000628:therapy*; D059467:Transcriptome
chemical_list: D014408:Biomarkers, Tumor